Evidence map›Paper›PMID 34696508›Full record

ArticleViruses2021

The Expression Level of HIV-1 Vif Is Optimized by Nucleotide Changes in the Genomic SA1D2prox Region during the Viral Adaptation Process.

Takaaki Koma, Naoya Doi, Mai Takemoto, Kyosuke Watanabe, Hideki Yamamoto, Satoshi Nakashima, Akio Adachi, Masako Nomaguchi

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Takaaki KomaDepartment of Microbiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan.ORCID 0000-0001-9767-990X
Naoya DoiDepartment of Microbiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan.
Mai TakemotoDepartment of Microbiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan.
Kyosuke WatanabeDepartment of Microbiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan.
Hideki YamamotoDepartment of Microbiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan.
Satoshi NakashimaDepartment of Microbiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan.
Akio AdachiDepartment of Microbiology, Kansai Medical University, Osaka 573-1010, Japan.
Masako NomaguchiDepartment of Microbiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan.
Tokushima University · JPKansai Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 Vif plays an essential role in viral replication by antagonizing anti-viral cellular restriction factors, a family of APOBEC3 proteins. We have previously shown that naturally-occurring single-nucleotide mutations in the SA1D2prox region, which surrounds the splicing acceptor 1 and splicing donor 2 sites of the HIV-1 genome, dramatically alter the Vif expression level, resulting in variants with low or excessive Vif expression. In this study, we investigated how these HIV-1 variants with poor replication ability adapt and evolve under the pressure of APOBEC3 proteins. Adapted clones obtained through adaptation experiments exhibited an altered replication ability and Vif expression level compared to each parental clone. While various mutations were present throughout the viral genome, all replication-competent adapted clones with altered Vif expression levels were found to bear them within SA1D2prox, without exception. Indeed, the mutations identified within SA1D2prox were responsible for changes in the Vif expression levels and altered the splicing pattern. Moreover, for samples collected from HIV-1-infected patients, we showed that the nucleotide sequences of SA1D2prox can be chronologically changed and concomitantly affect the Vif expression levels. Taken together, these results demonstrated the importance of the SA1D2prox nucleotide sequence for modulating the Vif expression level during HIV-1 replication and adaptation.

Indexed as

Adaptation, PhysiologicalAnti-Retroviral AgentsAPOBEC DeaminasesBase SequenceCD4-Positive T-LymphocytesDNA, ViralGene ExpressionGene Expression Regulation, ViralGenome, ViralGenomicsHEK293 CellsHIV-1HIV InfectionsHumansRNA Splice SitesRNA, ViralAnti-Retroviral AgentsAPOBEC3 proteins, humanAPOBEC DeaminasesDNA, ViralRNA Splice SitesRNA, Viralvif Gene Products, Human Immunodeficiency Virusvif protein, Human immunodeficiency virus 1adaptationHIV-1nucleotide sequenceSA1D2proxsplicingVif expression

Identifiers

PMID34696508
PMCPMC8537775
OpenAlexW3206720515

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.